Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Go back to Regeneron's blockbuster eye drug posts weaker sales due to inventory impact| Regeneron (NASDAQ: REGN) | Delayed: 751.44 -36.6 (4.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $788.04 | 52 Week High | $592.36 | |||
| Open | $778.09 | 52 Week Low | $325.35 | |||
| Day High | $780.95 | P/E | 197.23 | |||
| Day Low | $751.12 | EPS | $3.81 | |||
| Volume | 448,382 | |||||

